BioSpace News Archive

The meditation and sleep app, part of Kaiser Permanente’s self-care portfolio, supports people looking for ways to manage stress and build resilience, particularly in uncertain times.

St. Elizabeth Healthcare has been selected as the first site of the FDA-approved Phase-2 COVID-19 clinical trial studying the drug PUL-042 of Pulmotect, Inc ., in partnership with CTI Clinical Trial and Consulting Services (CTI), a global full-service contract research organization. The clinical trial will study the safety and efficacy

Enables advanced integration of PA 800 Plus with Waters Empower 3 Chromatography Data Software for data integrity compliance, reducing regulatory risk and maximizing method transfer efficiency FRAMINGHAM, Mass.--( BUSINESS WIRE )-- SCIEX , a global leader in life science analytical technologies, announced today the launch of its much anticipated SCIEX Empower Driver version 1.3, a software interface that gives users direct control of their PA 800 Plu

Deep Lens, a software company focused on a groundbreaking approach to faster recruitment of the best-suited cancer patients to clinical trials, has integrated proprietary molecular data parsing and management technology into the company’s award-winning clinical trial screening and enrollment platform, VIPER™

Erhardt was previously Senior Vice President, Head of Clinical Development & Operations at Pfizer --

Herbalife Nutrition Ltd. (NYSE: HLF) (the “Company”) today announced that it, together with HLF Financing, Inc., a wholly owned subsidiary of the Company, intends, subject to market and other conditions, to offer $600 million aggregate principal amount of senior notes due 2025 (the “Notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act

Thermedical ® , a developer of thermal-ablation medical systems to treat ventricular tachycardia (VT), today announced that it has received Breakthrough Device Designation from the U.S. Food & Drug Administration (FDA) for its Saline Enhanced Radiofrequency (SERF) Ablation system and Durablate® catheter. The FDA Breakthrough Devices Program is intended to help patients receive more timely access to technologies tha

Sommetrics , Inc., which provides products to treat airway obstruction during sleep and in acute care settings, announced today that its quality management system has been certified to the rigorous ISO 13485:2016 standard. During the audit process required for certification, Sommetrics was also evaluated and found to be in compliance with the standards of the Medical Device Single Audit Program (MDSAP) for Canada. “This is

MOSES for urinary stones and BPH treatments demonstrates 20% faster procedures and same day discharge, supporting value-based health care for patients and care-providers 1 YOKNE’AM ILLIT, Israel--( BUSINESS WIRE )-- Lumenis Ltd, the world’s largest energy-based medical device company for aesthetic, surgical, and ophthalmic applications, is pleased to share that 85% of “Honor Roll List” hospitals ( as selected by the 2019-2020 US News and World Report

Pear Therapeutics, Inc. , the leader in prescription digital therapeutics (PDTs), today announced the company has been selected as the winner of the Digital Health Innovation Award in the 2020 MedTech Breakthrough Awards Program. MedTech Breakthrough is an independent market intelligence organization that recognizes top companies, technologies, and products in the global health and medical technology market.